Clinical Trials Sponsored by Lopburi Cancer Hospital

Total 9741 results

Fujian Cancer Hospital

Not yet recruiting

POF Versus FOLFOX Plus IP Paclitaxel in AGC

Gastric Cancer
Henan Cancer Hospital

Recruiting

Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903) (HCHTOG1903)

Esophageal Squamous Cell Carcinoma

China
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

Classical Hodgkin Lymphoma

China
Henan Cancer Hospital

Recruiting

Study of CT and MR in the Lung Cancer

MRI | Genes | Response | Lung Cancer Squamous Cell | CT

China
Zhejiang Cancer Hospital

Recruiting

Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma

Gastric Adenocarcinoma

China
Barretos Cancer Hospital

Recruiting

Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma (INDUCTION)

Locally Advanced Malignant Neoplasm

Brazil
Fujian Cancer Hospital

Recruiting

A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer

Gastric Cancer Stage III

China
Zhejiang Cancer Hospital

Recruiting

Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma (Neo-DRATEC)

Surgery | Esophageal Carcinoma | Neoadjuvant Chemoradiotherapy

China
Zhejiang Cancer Hospital

Recruiting

Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions

Neoplasm Metastasis | Nasopharyngeal Cancer

China
Zhejiang Cancer Hospital

Completed

Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Henan Cancer Hospital

Completed

Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer

Chemotherapy-induced Nausea and Vomiting

China
Henan Cancer Hospital

Withdrawn

Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Breast Cancer Patients

Stage IV Breast Cancer

China
Henan Cancer Hospital

Withdrawn

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Breast Cancer | HER2-positive Breast Cancer

China
Fujian Cancer Hospital

Enrolling by invitation

Metronomic Oral Vinorelbine Combination With Tislelizumab in EGFR/ALK-negative Advanced NSCLC

EGFR/ ALK-negative Advanced NSCLC

China
Zhejiang Cancer Hospital

Active, not recruiting

Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study. (NSCLC)

Non-small Cell Lung Cancer | PDL1 Gene Mutation

China
Zhejiang Cancer Hospital

Completed

PTC Guiding Neoadjuvant Treatment in Breast Cancer

Pathological Conditions, Signs and Symptoms

China
Henan Cancer Hospital

Active, not recruiting

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma

China
Henan Cancer Hospital

Completed

A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity

Early Breast Cancer

China
Zhejiang Cancer Hospital

Completed

The 90% Effective Flow of High Flow Nasal Oxygenation (HFNO) During Sedated Bronchoscopy (HFNO)

Hypoxia

China
Zhejiang Cancer Hospital

Active, not recruiting

A Multi-omics-based Metabolic Typing Study of Gastric Cancer

Gastric Cancer | Diagnosis | Multi-omics

China
Zhejiang Cancer Hospital

Active, not recruiting

A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC

Lung Cancer, Small Cell

China
Henan Cancer Hospital

Active, not recruiting

A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

HER2 Positive Metastatic Breast Cancer

China
Zhejiang Cancer Hospital

Completed

Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma

Glioblastoma

China
Hunan Cancer Hospital

Completed

Real World Study on the Efficacy and Safety of Anti-HER2 Therapy

Breast Neoplasms | HER2-positive Breast Cancer

China
Zhejiang Cancer Hospital

Active, not recruiting

Mechanism of Gastric Signet Ring Cell Carcinoma Based on Microproteomics

Gastric Cancer | Signet Ring Cell Carcinoma

China
Fujian Cancer Hospital

Enrolling by invitation

An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas

Malignant Melanomas

China
Henan Cancer Hospital

Completed

Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC

Extensive Disease Small Cell Lung Cancer

China
Henan Cancer Hospital

Completed

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.

HER2 Positive Breast Cancer

China
Henan Cancer Hospital

Withdrawn

GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel

Early Breast Cancer

China
Zhejiang Cancer Hospital

Completed

Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

Endobronchial Metastases | Bronchoesophageal Fistula | General Anesthetic Drug Adverse Reaction

China
Henan Cancer Hospital

Completed

Application of Painting Analysis and Psychotherapy in Children With Bone Tumors

Bone Tumors

China
Hunan Cancer Hospital

Completed

Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer (ACTDNA)

Metastatic Breast Cancer | Circulating Tumor DNA | Gene Abnormality
Henan Cancer Hospital

Completed

Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule

Soft Tissue Sarcomas

China
Fujian Cancer Hospital

Enrolling by invitation

Tislelizumab as Cross-line Treatment for Advanced NSCLC

Advanced Non-small-cell Lung Cancer

China
Fujian Cancer Hospital

Withdrawn

Study of FMT Combined With Nivolumab in Gastric Cancer

Gastric Adenocarcinoma | Esophagus Adenocarcinoma | Esophagogastric Junction Adenocarcinoma

China
Barretos Cancer Hospital

Completed

Emotional Impact of the Way Conducting Cancer Patients to the Surgical Center

Depression | Anxiety Disorders

Brazil
Fujian Cancer Hospital

Unknown

Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC

Nasopharyngeal Carcinoma

China
Fujian Cancer Hospital

Completed

POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC

Malignant Neoplasm of Stomach Stage IV

China
Fujian Cancer Hospital

Withdrawn

Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma

Colorectal Adenocarcinoma

China
Fujian Cancer Hospital

Completed

Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration

Cancer Pain

China
Fujian Cancer Hospital

Completed

To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Completed

Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer

Breast Cancer | HER2 | Preoperative Systemic Treatment
Zhejiang Cancer Hospital

Unknown

TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong)

Carcinoma, Hepatocellular
Fujian Cancer Hospital

Unknown

Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain

Opioid, Moderate Cancer Pain, Transdermal Fentanyl, 12.5ug/h, Opioid-naive
Henan Cancer Hospital

Completed

Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma

Esophageal Cancer

China
Zhejiang Cancer Hospital

Unknown

Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis

Nasopharyngeal Carcinoma

China
Henan Cancer Hospital

Unknown

the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

Chemotherapy-induced Nausea and Vomiting | Tumor

China
Henan Cancer Hospital

Unknown

Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer

Small Cell Lung Cancer | Chemotherapy | Adoptive Cellular Immunotherapy | Maintenance | Extensive Disease

China
Henan Cancer Hospital

Unknown

The Real World Study of Apatinib for Gastric Cancer Treatment in Henan Province

Gastric Cancer

China
Henan Cancer Hospital

Unknown

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

Diffuse Large B-cell Lymphoma

China

3

Subscribe